Cargando…
Clinical evaluation of traditional Chinese medicine on mild active ulcerative colitis: A multi-center, randomized, double-blind, controlled trial
INTRODUCTION: Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) characterized by a relapsing-remitting course owing to recurrent intestinal inflammation. UC often has symptoms such as intermittent rectal bleeding, diarrhea, and abdominal pain. As the precise etiology of UC has no...
Autores principales: | Kou, Fu-Shun, Shi, Lei, Li, Jun-Xiang, Wang, Zhi-Bin, Shi, Rui, Mao, Tang-You, Ke, Xiao, Zhang, Bei-Ping, Yang, Xiao-Jun, Wen, Xin-Li, Zheng, Wei-Yang, Han, Xiao, Ding, Pang-Hua, Dong, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458163/ https://www.ncbi.nlm.nih.gov/pubmed/32871923 http://dx.doi.org/10.1097/MD.0000000000021903 |
Ejemplares similares
-
Efficacy of erzhu jiedu recipe on hepatitis B cirrhosis with hyperalphafetoproteinemia: A randomized, double-blind, placebo-controlled clinical trial
por: Chen, Tian-Yang, et al.
Publicado: (2021) -
Efficacy of resveratrol for the treatment in patients with ulcerative colitis: Study Protocol
por: Chen, Yan-hui, et al.
Publicado: (2019) -
A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48
por: Liang, Rong-Yue, et al.
Publicado: (2019) -
Intervention of Compound Xueshuantong Capsule on the incidence of heart failure in patients with acute myocardial infarction after PCI based on the combination of disease and syndrome: A multi-center, randomized, double-blind, controlled trial
por: Yang, Xiao-Dan, et al.
Publicado: (2022) -
A 12 week, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of HT083 on mild osteoarthritis
por: Lee, Donghun, et al.
Publicado: (2020)